日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Introducing CAR-T Therapy in Kazakhstan: Establishing Academic-Scale Lentiviral Vector and CAR-T Cell Production.

在哈萨克斯坦引入 CAR-T 疗法:建立学术规模的慢病毒载体和 CAR-T 细胞生产

Keyer Viktoriya, Kydyrbayeva Aitolkyn, Kulatay Tolganay, Zauatbayeva Gulzat, Bazhenov Dmitrii, Ingirbay Bakytkali, Shakhmanova Zhanar, Zhumabekova Maral, Ospanova Madina, Shustov Alexandr V

Synthetic genomics-based generation of the tick-borne encephalitis virus Siberian subtype prototype strain and E51K-attenuated variant for vaccine development and antiviral screening

利用合成基因组学方法构建蜱传脑炎病毒西伯利亚亚型原型毒株及其E51K减毒变异株,用于疫苗研发和抗病毒筛选

Kulatay, Tolganay; Sedova, Elena; Shevtsov, Alexander; Zauatbayeva, Gulzat; Ingirbay, Bakytkali; Keyer, Viktoriya; Shakhmanova, Zhanar; Zhumabekova, Maral; Abduraimov, Yergali; Rsaliyev, Aralbek; Sikhayeva, Nurgul; Kozlova, Irina; Zaripov, Mikhail; Shustov, Alexandr V

Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked.

中亚地区抗击SARS-CoV-2的甘草提取物及其他疗法:可获得但却被忽视

Zhurinov Murat Zh, Miftakhova Alfira F, Keyer Viktoriya, Shulgau Zarina T, Solodova Elena V, Kalykberdiyev Maxat K, Abilmagzhanov Arlan Z, Talgatov Eldar T, Ait Sauyk, Shustov Alexandr V

Synthesis and Antiviral Properties against SARS-CoV-2 of Epoxybenzooxocino[4,3-b]Pyridine Derivatives.

环氧苯并氧杂环辛烯[4,3-b]吡啶衍生物的合成及其对SARS-CoV-2的抗病毒性能

Stalinskaya Alena L, Martynenko Nadezhda V, Shulgau Zarina T, Shustov Alexandr V, Keyer Viktoriya V, Kulakov Ivan V